Author

Yanling Zhang

Harvard UniversityORCID 0000-0003-3496-1822Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Yanling Zhang1 paper · Tsinghua University

Biology Disciplines

Click to filter author papers

Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Alona MuzikanskyiD· 1 shared Anat O Stemmer-RachamimoviD· 1 shared Athena Ching‐Jung Wang· 1 shared Chao ZhuiD· 1 shared Gino B. FerraroiD· 1 shared Grace Y. LeeiD· 1 shared Jianren MaoiD· 1 shared John W. CheniD· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Alona MuzikanskyORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

NeurosciencebioRxivPreprintFeb 6, 2023

Co-Targeting IL-6 and EGFR signaling for the treatment of schwannomatosis and associated pain

Zhenzhen Yin, Limeng Wu, Yanling Zhang…·Lei Xu

This study identifies IL-6 and EGFR signaling as therapeutic targets for schwannomatosis, showing combined blockade reduces both pain and tumor growth in preclinical models.

5 citations

humanbulk RNA-seq

𝕏 PostBluesky